Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Weight-Loss drug ease heart failure? new trial begins

NCT ID NCT06820099

Recruiting now Disease control Sponsor: Shandong Suncadia Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 27 times

Summary

This study tests an experimental drug called HRS-7535 in 225 adults who have both heart failure (with a mildly reduced or preserved pumping ability) and obesity. The main goal is to see if the drug helps with weight loss and reduces inflammation over 36 weeks. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor their doctors will know which they get.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fuwai Hospital, Chinese Academy of Medical Sciences

    RECRUITING

    Beijing, Beijing Municipality, 100032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY